BlackRock, Inc. 13D and 13G filings for Ocular Therapeutix, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | Ocular Therapeutix, Inc. OCUL |
BlackRock Inc. BLK |
11,354,164 7.300% |
0 (Unchanged) |
Filing |
| 2024-10-22 6:06 pm Purchase |
2024-09-30 | 13G | Ocular Therapeutix, Inc. OCUL |
BlackRock Inc. BLK |
11,354,164 7.300% |
5,592,631 (+97.07%) |
Filing |
| 2024-01-31 2:08 pm Purchase |
2023-12-31 | 13G | Ocular Therapeutix, Inc. OCUL |
BlackRock Inc. BLK |
5,761,533 5.200% |
808,796 (+16.33%) |
Filing |
| 2023-01-31 5:52 pm Sale |
2022-12-31 | 13G | Ocular Therapeutix, Inc. OCUL |
BlackRock Inc. BLK |
4,952,737 6.400% |
-170,098 (-3.32%) |
Filing |
| 2022-02-02 7:11 pm Sale |
2021-12-31 | 13G | Ocular Therapeutix, Inc. OCUL |
BlackRock Inc. BLK |
5,122,835 6.700% |
-389,429 (-7.06%) |
Filing |
| 2021-02-02 3:13 pm Purchase |
2020-12-31 | 13G | Ocular Therapeutix, Inc. OCUL |
BlackRock Inc. BLK |
5,512,264 7.300% |
2,506,097 (+83.37%) |
Filing |
| 2020-06-09 4:32 pm Purchase |
2020-05-31 | 13G | Ocular Therapeutix, Inc. OCUL |
BlackRock Inc. BLK |
3,006,167 4.800% |
176,523 (+6.24%) |
Filing |